Serial Transfer of Single-Cell-Derived Immunocompetence Reveals Stemness of CD8+ Central Memory T Cells

Cited by (312)

Items 101–200 of 312

  1. Single-Cell RNA-Seq Analysis Uncovers Distinct Functional Human NKT Cell Sub-Populations in Peripheral Blood
    Li Zhou, Indra Adrianto, Jie Wang, Xiaojun Wu, Indrani Datta, Qing‐Sheng Mi · 2020 · Frontiers in Cell and Developmental Biology
  2. L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice
    Hao Hong, Christine E. Brown, Julie R. Ostberg, Saul J. Priceman, Wen-Chung Chang, Lihong Weng, Paul Lin, Mark Tsuneo Wakabayashi, Michael C. Jensen, Stephen J. Forman · 2016 · PLoS ONE
  3. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic
    Kinga Majchrzak, Michelle Hase Nelson, Stefanie R. Bailey, Jacob S. Bowers, Xue‐Zhong Yu, Mark P. Rubinstein, Richard A. Himes, Chrystal Mary Paulos · 2016 · Cancer Immunology Immunotherapy
  4. Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway
    Hassen Kared, Shu Wen Tan, Mai Chan Lau, Marion Chevrier, Crystal Tze Ying Tan, Wilson How, Glenn Choon Lim Wong, Marie Strickland, Benoît Malleret, Amanda Amoah et al. · 2020 · Nature Communications
  5. Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
    Cheng Zhang, Jiaping He, Li Liu, Jishi Wang, Sanbin Wang, Ligen Liu, Jian Ge, Lei Gao, Li Gao, Peiyan Kong et al. · 2022 · Blood Cancer Journal
  6. Schrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion
    Nancy M. Gonzalez, Dawei Zou, Andy Gu, Wenhao Chen · 2021 · Frontiers in Immunology
  7. The Quantity of Autocrine IL-2 Governs the Expansion Potential of CD8+ T Cells
    Anke Redeker, Suzanne P. M. Welten, Miranda R.M. Baert, Sandra A. Vloemans, Machteld M. Tiemessen, Frank J. T. Staal, Ramon Arens · 2015 · The Journal of Immunology
  8. Wuchereria bancrofti-infected individuals harbor distinct IL-10-producing regulatory B and T cell subsets which are affected by anti-filarial treatment
    Manuel Ritter, Jubin Osei-Mensah, Linda Batsa Debrah, Alexander Kwarteng, Yusif Mubarik, Alexander Yaw Debrah, Kenneth M. Pfarr, Achim M. Hoerauf, Laura E. Layland · 2019 · PLoS neglected tropical diseases
  9. β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity
    Kinga Majchrzak, Michelle Hase Nelson, Jacob S. Bowers, Stefanie R. Bailey, Megan M. Wyatt, John M. Wrangle, Mark P. Rubinstein, Juan Carlos Varela, Zihai Li, Richard A. Himes et al. · 2017 · JCI Insight
  10. CD8+ T cell diversification by asymmetric cell division
    Michael Floßdorf, Jens Rößler, Veit R. Buchholz, Dirk Hans Busch, Thomas Höfer · 2015 · Nature Immunology
  11. Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression
    Sarah Dötsch, Mortimer Svec, Kilian Schober, Monika Hammel, Andreas Wanisch, Füsun Gökmen, Sebastian Jarosch, Linda Warmuth, Jack Barton, Luka Čičin‐Šain et al. · 2023 · Proceedings of the National Academy of Sciences
  12. Common gamma chain cytokines and CD8 T cells in cancer
    Mitra Shourian, Jean‐Christophe Beltra, Benoîte Bourdin, Hélène Decaluwe · 2019 · Seminars in Immunology
  13. Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes
    Noam Levin, Sanghyun Peter Kim, Charles Marquardt, Nolan R. Vale, Zhiya Yu, Sivasish Sindiri, Jared J. Gartner, Maria R. Parkhurst, Sri Krishna, Frank J. Lowery et al. · 2024 · Journal for ImmunoTherapy of Cancer
  14. Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype
    Tessa Gargett, Nga TH Truong, Lisa M. Ebert, Wenbo Yu, Michael Paul Brown · 2019 · Cytotherapy
  15. Integrating resident memory into T cell differentiation models
    Pamela C. Rosato, Sathi Wijeyesinghe, James Michael Stolley, David Masopust · 2020 · Current Opinion in Immunology
  16. CARs: Beyond T Cells and T Cell-Derived Signaling Domains
    Nico Manuel Sievers, Jan Dörrie, Niels Schaft · 2020 · International Journal of Molecular Sciences
  17. Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells
    Alessandro Allegra, Vanessa Innao, Demetrio Gabriele Gerace, Doriana Vaddinelli, Caterina Musolino · 2016 · Blood Cells Molecules and Diseases
  18. Regulation of effector and memory CD8+ T cell function by inflammatory cytokines
    Stefanie F. Valbon, Stephanie A. Condotta, Martin J. Richer · 2015 · Cytokine
  19. Lack of p53 Augments Antitumor Functions in Cytolytic T Cells
    Anirban Banerjee, Krishnamurthy Thyagarajan, Shilpak Chatterjee, Paramita Chakraborty, Pravin Kesarwani, Myroslawa Soloshchenko, Mazen Al-Hommrani, Kristina Andrijauskaite, Kelly M. Moxley, Harinarayanan Janakiraman et al. · 2016 · Cancer Research
  20. Chimeric Antigen Receptors: A Paradigm Shift in Immunotherapy
    Michel Sadelain · 2017 · Annual Review of Cancer Biology
  21. TCR repertoire evolution during maintenance of CMV ‐specific T‐cell populations
    Kilian Schober, Veit R. Buchholz, Dirk Hans Busch · 2018 · Immunological Reviews
  22. Adoptive therapy with cytomegalovirus ‐specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy
    Xuying Pei, Xiang‐Yu Zhao, Xue‐Fei Liu, Xiao‐Dong Mo, Meng Lv, Lan‐Ping Xu, Yu Wang, Ying‐Jun Chang, Xiaohui Zhang, Kai‐Yan Liu et al. · 2022 · American Journal of Hematology
  23. Immunotherapeutic Potential of T Memory Stem Cells
    Yujie Li, Dengqiang Wu, Xuejia Yang, Sufang Zhou · 2021 · Frontiers in Oncology
  24. Memory T Cells Specific for Murine Cytomegalovirus Re-Emerge after Multiple Challenges and Recapitulate Immunity in Various Adoptive Transfer Scenarios
    Michael A. Quinn, Holly Turula, Mayank Tandon, Berthony Deslouches, Toktam Moghbeli, Christopher M. Snyder · 2015 · The Journal of Immunology
  25. The Potential of Tissue-Resident Memory T Cells for Adoptive Immunotherapy against Cancer
    Ammarina Beumer‐Chuwonpad, Renske L. R. E. Taggenbrock, T. An Ngo, Klaas P. J. M. van Gisbergen · 2021 · Cells
  26. T cell responses to control fungal infection in an immunological memory lens
    Jaishree Sharma, Srinivasu Mudalagiriyappa, Som Gowda Nanjappa · 2022 · Frontiers in Immunology
  27. Generating long‐lived CD8+ T‐cell memory: Insights from epigenetic programs
    Pranay Dogra, Hazem E. Ghoneim, Hossam Aly Abdelsamed, Ben Youngblood · 2016 · European Journal of Immunology
  28. Cytomegalovirus memory inflation and immune protection
    Luka Čičin‐Šain · 2019 · Medical Microbiology and Immunology
  29. Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
    Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Fatemeh Rahbarizadeh · 2021 · Frontiers in Immunology
  30. Two sides of the same coin: Protective versus pathogenic CD4 + resident memory T cells
    Anna E. Oja, René A. W. van Lier, Pleun Hombrink · 2022 · Science Immunology
  31. Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells
    Blandine Caël, Jeanne Galaine, Isabelle Bardey, Chrystel Marton, Maxime Fredon, Sabeha Biichlé, Margaux Poussard, Yann Godet, Fanny Angelot‐Delettre, Christophe Barisien et al. · 2022 · Cancers
  32. AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival
    Vedika Mehra, Giulia Agliardi, Juliana Dias, Manar S. Shafat, Amaia Cadiñanos-Garai, Louisa Green, Alastair Hotblack, Frederick Arce Vargas, Karl S. Peggs, Anniek B. van der Waart et al. · 2023 · Journal for ImmunoTherapy of Cancer
  33. Induction of immortal-like and functional CAR T cells by defined factors
    Lixia Wang, Gang Jin, Qiuping Zhou, Yanyan Liu, Xiaocui Zhao, Zhuoyang Li, Na Yin, Min Peng · 2024 · The Journal of Experimental Medicine
  34. Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options
    Shigeo Fuji, Hermann Einsele, Markus Kapp · 2017 · Current Opinion in Infectious Diseases
  35. Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 + T cells
    Jan A. Rath, Gagan Bajwa, Benoît M. Carrères, Elisabeth A. Hoyer, Isabelle Gruber, Melisa A. Martinez-Paniagua, Yi-Ru Yu, Nazila Nouraee, Fatemeh Sadeghi, Meng‐Fen Wu et al. · 2020 · Science Advances
  36. Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity
    Guillermo O. Rangel Rivera, Connor J. Dwyer, Hannah M. Knochelmann, Aubrey S. Smith, Bülent Arman Aksoy, Anna C. Cole, Megan M. Wyatt, Soundharya Kumaresan, Jessica E. Thaxton, Gregory B. Lesinski et al. · 2023 · Cancer Research
  37. Comparison of naïve and central memory derived CD8 + effector cell engraftment fitness and function following adoptive transfer
    Xiuli Wang, ChingLam W. Wong, Ryan Z. Urak, Ellie Taus, Brenda Aguilar, Wen-Chung Chang, Armen Mardiros, Lihua Elizabeth Budde, Christine E. Brown, Carolina Berger et al. · 2015 · OncoImmunology
  38. Area under Immunosurveillance: Dedicated Roles of Memory CD8 T-Cell Subsets
    Loreto Parga Vidal, Klaas P. J. M. van Gisbergen · 2020 · Cold Spring Harbor Perspectives in Biology
  39. Circulating memory CD8 + T cells are limited in forming CD103 + tissue‐resident memory T cells at mucosal sites after reinfection
    Behr, Felix M., Beumer‐Chuwonpad, Ammarina, Kragten, Natasja A. M., Wesselink, Thomas H., Stark, Regina, van Gisbergen, Klaas P. J. M. · 2021 · European Journal of Immunology
  40. Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy
    Dawei Zou, X.C. Li, Wenhao Chen · 2025 · Cellular and Molecular Immunology
  41. From T cell “exhaustion” to anti-cancer immunity
    Grégory Verdeil, Silvia A. Fuertes Marraco, Timothy J. Murray, Daniel E. Speiser · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  42. Curtailed T‐cell activation curbs effector differentiation and generates CD8+ T cells with a naturally‐occurring memory stem cell phenotype
    Veronica Zanon, Karolina Pilipow, Eloise Scamardella, Fédérica De Paoli, Gabriele De Simone, David A. Price, Amaia Martínez-Usatorre, Pedro J. Romero, Domenico Mavilio, Alessandra Roberto et al. · 2017 · European Journal of Immunology
  43. Control of Cytomegalovirus Viremia after Allogeneic Stem Cell Transplantation: A Review on CMV-Specific T Cell Reconstitution
    Pim van der Heiden, Erik W.A. Marijt, Fred Falkenburg, Inge Jedema · 2018 · Transplantation and Cellular Therapy
  44. The future of immunotherapy for sarcoma
    Tomohide Tsukahara, Makoto Emori, Kenji Murata, Emi Mizushima, Yuji Shibayama, Terufumi Kubo, Takayuki Kanaseki, Yoshihiko Hirohashi, Toshihiko Yamashita, Noriyuki Sato et al. · 2016 · Expert Opinion on Biological Therapy
  45. Recurrence of Melanoma Following T Cell Treatment: Continued Antigen Expression in a Tumor That Evades T Cell Recruitment
    Trudy Straetemans, Cor Berrevoets, Miriam Coccoris, Elike Treffers-Westerlaken, Rebecca Wijers, David K. Cole, Valérie Dardalhon, Andrew Kelvin Sewell, Naomi N. Taylor, Jaap Verweij et al. · 2014 · Molecular Therapy
  46. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma
    Felicitas Rataj, Fabian Bernhard Thaddäus Kraus, Michael Chaloupka, Simon A. Grassmann, Constanze Heise, Bruno Loureiro Cadilha, Peter Duewell, Stefan Endres, Sebastian Kobold · 2018 · Frontiers in Immunology
  47. HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
    Zhengtao Jiang, Huitong Liang, Hanyu Pan, Liang Yue, Hua Wang, Xinyi Yang, Panpan Lu, Xiao Zhang, Jinlong Yang, Dengji Zhang et al. · 2021 · Frontiers in Microbiology
  48. The Tmod cellular logic gate as a solution for tumor-selective immunotherapy
    Breanna DiAndreth, Agnes E. Hamburger, Xu Han, Alexander Kamb · 2022 · Clinical Immunology
  49. Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells
    Michiel C. van Aalderen, Ester B. M. Remmerswaal, Kirstin M. Heutinck, Anja ten Brinke, Mariet C.W. Feltkamp, Neelke C. van der Weerd, K.A.M.I. van Donselaar–van der Pant, Fréderike J. Bemelman, René A. W. van Lier, Ineke J. M. ten Berge · 2016 · PLoS Pathogens
  50. Heritable changes in division speed accompany the diversification of single T cell fate
    Marten Plambeck, Atefeh Kazeroonian, Dirk Loeffler, Lorenz Kretschmer, Ciro Salinno, Timm Schroeder, Dirk Hans Busch, Michael Floßdorf, Veit R. Buchholz · 2022 · Proceedings of the National Academy of Sciences
  51. Promises and challenges of mucosal COVID-19 vaccines
    Abhay P. S. Rathore, Ashley L. St. John · 2023 · Vaccine
  52. Emergence and fate of stem cell–like Tcf7 + CD8 + T cells during a primary immune response to viral infection
    Joana Gomes da Silva, Daniela Pais Ferreira, Alexandre Dumez, Tania Wyss, Romain Veber, Maxime Danilo, Daniel D. Pinschewer, Mélanie Charmoy, Werner Held · 2023 · Science Immunology
  53. IL-21-armored B7H3 CAR-iNKT cells exert potent antitumor effects
    Y Liu, Yuanyuan Dang, Chuhan Zhang, Liu Liu, Wenhui Cai, Liantao Li, Lin Fang, Meng Wang, Shunzhe Xu, Gang Wang et al. · 2023 · iScience
  54. Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
    Valérie Janelle, Cédric Carli, Julie Taillefer, Julie Orio, Jean‐Sébastien Delisle · 2015 · Journal of Translational Medicine
  55. TNIK signaling imprints CD8+ T cell memory formation early after priming
    Carla A. Jaeger-Ruckstuhl, Magdalena Hinterbrandner, Sabine Höpner, Colin Correnti, Ursina Lüthi, Olivier Friedli, Stefan Freigang, Mohamad F. Al Sayed, Elias D. Bührer, Michael A. Amrein et al. · 2020 · Nature Communications
  56. Divergent Clonal Differentiation Trajectories Establish CD8 + Memory T Cell Heterogeneity During Acute Viral Infections in Humans
    Jeff Eron Mold, Laurent Modolo, Joanna Hård, Margherita Zamboni, Anton J. M. Larsson, Moa Stenudd, Carl‐Johan Eriksson, Ghislain Durif, Patrik L. Ståhl, Erik Borgström et al. · 2020 · Cell Reports
  57. Signatures of recent activation identify a circulating T cell compartment containing tumor-specific antigen receptors with high avidity
    Anna Purcarea, Sebastian Jarosch, Jack Barton, Simon A. Grassmann, Ludwig O. Pachmayr, Elvira D’Ippolito, Monika Hammel, Anna Hochholzer, Karolin I. Wagner, Joost H. van den Berg et al. · 2022 · Science Immunology
  58. Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T Cells specifically inhibit Ewing sarcoma growthin vitroandin vivo
    Franziska Blaeschke, Uwe Thiel, A. Kirschner, Melanie Thiede, Rebeca Alba Rubío, David Schirmer, Thomas Kirchner, Günther H.S. Richter, Sabine Mall, Richard Klar et al. · 2016 · Oncotarget
  59. Metabolic checkpoints and novel approaches for immunotherapy against cancer
    Yiming Li, Juan Tang, Jian‐Li Jiang, Zhi‐Nan Chen · 2021 · International Journal of Cancer
  60. Effector memory–type regulatory T cells display phenotypic and functional instability
    Désirée J. Wendering, Leila Amini, Stephan Schlickeiser, Martí Farrera-Sal, Sarah Schulenberg, Lena Peter, Marco Mai, Tino Vollmer, Weijie Du, Maik Stein et al. · 2024 · Science Advances
  61. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
    Yikan Sun, Eloy Yinwang, Shengdong Wang, Zenan Wang, Fangqian Wang, Yucheng Xue, Wenkan Zhang, Shenzhi Zhao, Haochen Mou, Shixin Chen et al. · 2024 · Molecular Cancer
  62. Runx proteins and transcriptional mechanisms that govern memory CD8 T cell development
    Matthew E. Pipkin · 2021 · Immunological Reviews
  63. Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
    Noelia Maldonado‐Pérez, María Tristán‐Manzano, Pedro Justicia-Lirio, Elena Martínez-Planes, Pilar Muñoz, Kristina Pavlovic, Marina Cortijo-Gutierréz, Carlos Blanco-Benítez, María Castellà, Manel Juan et al. · 2022 · Frontiers in Immunology
  64. Memory T Cells Officially Join the Stem Cell Club
    Luca Gattinoni · 2014 · Immunity
  65. TGFβ Programs Central Memory Differentiation in Ex Vivo –Stimulated Human T Cells
    Amina Dahmani, Valérie Janelle, Cédric Carli, Manon Richaud, Caroline Lamarche, Myriam Khalili, Mathieu Goupil, Ksenia Bezverbnaya, Jonathan L. Bramson, Jean‐Sébastien Delisle · 2019 · Cancer Immunology Research
  66. Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma
    Richard Hopkins, Wenwei Xiang, Damien Marlier, Veonice Bijin Au, Qian Ting Ching, Lynn Xue Wu, Rujun Guan, Bernett Teck Kwong Lee, Whay-Kuang John Chia, Who-Whong Wang et al. · 2020 · Molecular Therapy
  67. Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells
    Jia Feng, Hai-chan Xu, Andrew Cinquina, Zehua Wu, Wenli Zhang, Lihua Sun, Qi Chen, Lei Tian, Le Song, Kevin G. Pinz et al. · 2022 · Frontiers in Immunology
  68. The Memory Immune Response to Tuberculosis
    Joanna R. Kirman, Marcela I. Henao-Tamayo, Else Marie Agger · 2016 · Microbiology Spectrum
  69. Revisiting CD8 T-cell ‘Memory Inflation’: New Insights with Implications for Cytomegaloviruses as Vaccine Vectors
    Rafaela Holtappels, Kirsten Freitag, Angélique Renzaho, Sara Becker, Niels A. W. Lemmermann, Matthias Johannes Reddehase · 2020 · Vaccines
  70. Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases
    Jianshu Zhu, Jiawei Fan, Yuanliang Xia, Hengyi Wang, Yuehong Li, Zijia Feng, Changfeng Fu · 2023 · Frontiers in Immunology
  71. CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection
    SuJin Hwang, Imtiaz A. Khan · 2015 · Seminars in Immunopathology
  72. Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies
    Thomas Kuilman, Deborah S. Schrikkema, Jules Gadiot, Raquel Gomez, Laura Bies, Julia Walker, Robbert M. Spaapen, Hanna Kok, Demi Houg, Milena Viyacheva et al. · 2025 · Nature Communications
  73. The Extracellular ATP Receptor P2RX7 Imprints a Promemory Transcriptional Signature in Effector CD8+ T Cells
    Trupti Vardam-Kaur, Sarah van Dijk, Changwei Peng, Kelsey Marie Wanhainen, Stephen C. Jameson, Henrique Borges da Silva · 2022 · The Journal of Immunology
  74. Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD
    Yewei Wang, Md Ashik Ullah, Olivia G. Waltner, Shruti S. Bhise, Kathleen S. Ensbey, Christine R. Schmidt, Samuel R.W. Legg, Tomoko Sekiguchi, Ethan L. Nelson, Rachel D. Kuns et al. · 2024 · Journal of Clinical Investigation
  75. Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
    Kilian Schober, Thomas R Müller, Dirk Hans Busch · 2020 · Cells
  76. Ablation of Wntless in endosteal niches impairs lymphopoiesis rather than HSCs maintenance
    Jingjing Cao, Lingling Zhang, Yong Wan, Hanjun Li, Rujiang Zhou, Heyuan Ding, Yongzhong Liu, Zhengju Yao, Xizhi Guo · 2015 · European Journal of Immunology
  77. ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells
    Rebar N. Mohammed, Sophie C. Wehenkel, Elena Galkina, Emma-Kate Yates, Graham Preece, Andrew Newman, H. Angharad Watson, Julia Ohme, John S. Bridgeman, Ruban Rex Peter Durairaj et al. · 2019 · Scientific Reports
  78. The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer Immunity: Lessons Learned From PD-1/PD-L1 Blockade Therapy and Remaining Gaps
    Silvia Gitto, Ambra Natalini, Fabrizio Antonangeli, Francesca Di Rosa · 2021 · Frontiers in Immunology
  79. Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches
    Siddhesh Mittra, Shane M. Harding, Susan M. Kaech · 2023 · The Journal of Immunology
  80. Silencing stemness in T cell differentiation
    Amanda N. Henning, Christopher Austin Klebanoff, Nicholas P. Restifo · 2018 · Science
  81. Emerging Role of CAR T Cells in Non-Hodgkin's Lymphoma
    Mauro P. Avanzi, Renier J. Brentjens · 2017 · Journal of the National Comprehensive Cancer Network
  82. Extrinsic and intrinsic drivers of natural killer cell clonality
    Timo Rückert, Chiara Romagnani · 2024 · Immunological Reviews
  83. Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells
    Fabian Schlott, Dominik Steubl, Stefanie Ameres, Andreas Moosmann, Stefan Dreher, Uwe W. Heemann, Volker Hösel, Dirk Hans Busch, Michael Neuenhahn · 2018 · PLoS ONE
  84. Predictive short/long-term efficacy biomarkers and resistance mechanisms of CD19-directed CAR-T immunotherapy in relapsed/refractory B-cell lymphomas
    Hao Xu, Ningwen Li, Gaoxiang Wang, Yang Cao · 2023 · Frontiers in Immunology
  85. Resident regulatory T cells reflect the immune history of individual lymph nodes
    Anne Kaminski, Fabian Tobias Hager, Lydia Kopplin, Fabio Ticconi, Andrea Leufgen, Emilia Vendelova, Lennart Rüttger, Georg Gasteiger, Vuk Cerovic, Wolfgang Kastenmüller et al. · 2023 · Science Immunology
  86. The Evolving Roles of Memory Immune Cells in Transplantation
    Wenhao Chen, Rafik Mark Ghobrial, X.C. Li · 2015 · Transplantation
  87. The prognostic value of TCF1+CD8+T in primary small cell carcinoma of the esophagus
    Lin Ma, Lijun Sun, Kaikai Zhao, Zhengxin Dong, Zhaoqin Huang, Xiangjiao Meng · 2021 · Cancer Science
  88. Biomarkers in Chimeric Antigen Receptor T-cell Therapy
    Weimin Kong, Simon Francis Lacey, Jan Joseph Melenhorst, Joseph A. Fraietta · 2018 · Biomarkers in Medicine
  89. Personalized gel-droplet monocyte vaccines for cancer immunotherapy
    Yishen Tian, Chun-Miao Xu, Feng Jiao, Yueyue Huangfu, Kai Wang, Zhiling Zhang · 2021 · Lab on a Chip
  90. Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells
    Vahid Yekehfallah, Saghar Pahlavanneshan, Ali Sayadmanesh, Zahra Momtahan, Bin Ma, Mohsen Basiri · 2022 · Biomolecules
  91. A transcriptome-based model of central memory CD4 T cell death in HIV infection
    Gustavo Olvera-García, Tania Aguilar-García, Fany Gutiérrez-Jasso, Iván Imaz-Rosshandler, Claudia Rangel‐Escareño, Lorena Orozco, Irma Aguilar-Delfín, Joel Armando Vázquez-Pérez, Joaquı́n Zúñiga, Santiago Pérez-Patrigeón et al. · 2016 · BMC Genomics
  92. Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvement
    Shalla Hanson, David Robert Grimes, Jake P. Taylor‐King, Benedikt Bauer, Pravnam I. Warman, Ziv Frankenstein, Artem Kaznatcheev, Michael J. Bonassar, Vincent L. Cannataro, Zeinab Y. Motawe et al. · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with ‘humanized’ antigen presentation as a new preclinical study tool
    Niels A. W. Lemmermann, Matthias Johannes Reddehase · 2016 · Medical Microbiology and Immunology
  94. Stability and flexibility in chromatin structure and transcription underlies memory CD8 T-cell differentiation
    Huitian Diao, Matthew E. Pipkin · 2019 · F1000Research
  95. Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma
    Piamsiri Sawaisorn, Korakot Atjanasuppat, Usanarat Anurathapan, Somchai Chutipongtanate, Suradej Hongeng · 2020 · Vaccines
  96. Stem-cell dynamics and lineage topology from in vivo fate mapping in the hematopoietic system
    Thomas Höfer, Melania Barile, Michael Floßdorf · 2016 · Current Opinion in Biotechnology
  97. Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis
    Xun Li, Tristan Wirtz, Timm Weber, Mikhail Y. Lebedin, Elijah David Lowenstein, Thomas G. Sommermann, Andreas Zach, Tomoharu Yasuda, Kathrin de la Rosa, Van Trung Chu et al. · 2024 · Science Immunology
  98. Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH)
    Kristoffer Weißert, Sandra Ammann, Tamara Kögl, Viviane Dettmer‐Monaco, Christoph Schell, Toni Cathomen, Stephan R. Ehl, Peter Aichele · 2022 · EMBO Molecular Medicine
  99. Early exposure to interleukin-21 limits rapidly generated anti–Epstein-Barr virus T-cell line differentiation
    Julie Orio, Cédric Carli, Valérie Janelle, Martin Giroux, Julie Taillefer, Mathieu Goupil, Manon Richaud, Denis‐Claude Roy, Jean‐Sébastien Delisle · 2015 · Cytotherapy
  100. Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase
    Biswajit Paul, Guillermo S. Romano Ibarra, Nicholas Hubbard, Teresa Einhaus, Alexander Astrakhan, David J. Rawlings, Hans‐Peter Kiem, Christopher W. Peterson · 2018 · Molecular Therapy — Methods & Clinical Development